Abbvie Inc (ABBV)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
12-2009 | |
Cash Flows From Operating Activities | |
Net Income | 4,636,510 |
Depreciation Amortization | 697,490 |
Other Working Capital | 503,740 |
Other Operating Activity | -470,410 |
Operating Cash Flow | $5,367,330 |
Cash Flows From Investing Activities | |
PPE Investments | -312,560 |
Net Acquisitions | -170,000 |
Other Investing Activity | -3,790 |
Investing Cash Flow | $-486,350 |
Cash Flows From Financing Activities | |
Other Financing Activity | -4,881,150 |
Financing Cash Flow | $-4,881,150 |
Beginning Cash Position | 200 |
End Cash Position | 30 |
Net Cash Flow | $-170 |
Free Cash Flow | |
Operating Cash Flow | 5,367,330 |
Free Cash Flow | 5,367,330 |